Hollsteen
← Oracle

Equity incl. NCI

Balance – as of period end · $B

QuartersFiscal years

$BEquity incl. NCI · Q1 FY2016: $47.5B · 10-Q 0001193125-15-323532 filed Sep 18, 2015Equity incl. NCI · Q2 FY2016: $46.3B · 10-Q 0001193125-15-407703 filed Dec 18, 2015Equity incl. NCI · Q3 FY2016: $46.3B · 10-Q 0001193125-16-510333 filed Mar 18, 2016Equity incl. NCI · Q4 FY2016: $47.8B · 10-K 0001193125-16-628942 filed Jun 22, 2016Equity incl. NCI · Q1 FY2017: $47.8B · 10-Q 0001193125-16-713596 filed Sep 19, 2016Equity incl. NCI · Q2 FY2017: $48.8B · 10-Q 0001193125-16-797253 filed Dec 19, 2016Equity incl. NCI · Q3 FY2017: $51.0B · 10-Q 0001193125-17-087309 filed Mar 17, 2017Equity incl. NCI · Q4 FY2017: $55.1B · 10-K 0001564590-19-023119 filed Jun 21, 2019Equity incl. NCI · Q1 FY2018: $56.4B · 10-Q 0001193125-17-287455 filed Sep 18, 2017Equity incl. NCI · Q2 FY2018: $56.3B · 10-Q 0001193125-17-372232 filed Dec 18, 2017Equity incl. NCI · Q3 FY2018: $49.1B · 10-Q 0001564590-19-008273 filed Mar 18, 2019Equity incl. NCI · Q4 FY2018: $46.9B · 10-K 0001564590-19-023119 filed Jun 21, 2019Equity incl. NCI · Q1 FY2019: $38.6B · 10-Q 0001564590-18-023315 filed Sep 19, 2018Equity incl. NCI · Q2 FY2019: $31.1B · 10-Q 0001564590-18-031113 filed Dec 19, 2018Equity incl. NCI · Q3 FY2019: $24.2B · 10-Q 0001564590-19-008273 filed Mar 18, 2019Equity incl. NCI · Q4 FY2019: $22.4B · 10-K 0001564590-19-023119 filed Jun 21, 2019Equity incl. NCI · Q1 FY2020: $19.0B · 10-Q 0001564590-19-034717 filed Sep 13, 2019Equity incl. NCI · Q2 FY2020: $16.2B · 10-Q 0001564590-19-045966 filed Dec 13, 2019Equity incl. NCI · Q3 FY2020: $14.9B · 10-Q 0001564590-20-010833 filed Mar 13, 2020Equity incl. NCI · Q4 FY2020: $12.7B · 10-K 0001564590-20-030125 filed Jun 22, 2020Equity incl. NCI · Q1 FY2021: $10.1B · 10-Q 0001564590-20-043448 filed Sep 15, 2020Equity incl. NCI · Q2 FY2021: $8.6B · 10-Q 0001564590-20-056896 filed Dec 11, 2020Equity incl. NCI · Q3 FY2021: $9.6B · 10-Q 0001564590-21-012539 filed Mar 11, 2021Equity incl. NCI · Q4 FY2021: $6.0B · 10-K 0001564590-21-033616 filed Jun 21, 2021Equity incl. NCI · Q1 FY2022: −$1.1B · 10-Q 0001564590-21-047772 filed Sep 13, 2021Equity incl. NCI · Q2 FY2022: −$9.7B · 10-Q 0001564590-21-060022 filed Dec 10, 2021Equity incl. NCI · Q3 FY2022: −$8.2B · 10-Q 0001564590-22-009859 filed Mar 11, 2022Equity incl. NCI · Q4 FY2022: −$5.8B · 10-K 0001564590-22-023675 filed Jun 21, 2022Equity incl. NCI · Q1 FY2023: −$5.4B · 10-Q 0001564590-22-031545 filed Sep 13, 2022Equity incl. NCI · Q2 FY2023: −$3.8B · 10-Q 0001564590-22-039278 filed Dec 13, 2022Equity incl. NCI · Q3 FY2023: −$1.9B · 10-Q 0001564590-23-003413 filed Mar 10, 2023Equity incl. NCI · Q4 FY2023: $1.6B · 10-K 0000950170-23-028914 filed Jun 20, 2023Equity incl. NCI · Q1 FY2024: $2.8B · 10-Q 0000950170-23-047713 filed Sep 12, 2023Equity incl. NCI · Q2 FY2024: $6.2B · 10-Q 0000950170-25-037143 filed Mar 11, 2025Equity incl. NCI · Q3 FY2024: $6.2B · 10-Q 0000950170-24-029904 filed Mar 12, 2024Equity incl. NCI · Q4 FY2024: $9.2B · 10-K 0000950170-24-075605 filed Jun 20, 2024Equity incl. NCI · Q1 FY2025: $11.3B · 10-Q 0000950170-24-104905 filed Sep 10, 2024Equity incl. NCI · Q2 FY2025: $14.2B · 10-Q 0000950170-24-134973 filed Dec 10, 2024Equity incl. NCI · Q3 FY2025: $17.3B · 10-Q 0000950170-25-037143 filed Mar 11, 2025Equity incl. NCI · Q4 FY2025: $21.0B · 10-K 0000950170-25-087926 filed Jun 18, 2025Equity incl. NCI · Q1 FY2026: $24.7B · 10-Q 0001193125-25-200095 filed Sep 10, 2025Equity incl. NCI · Q2 FY2026: $30.5B · 10-Q 0001193125-25-315925 filed Dec 11, 2025Equity incl. NCI · Q3 FY2026: $39.1B · 10-Q 0001193125-26-101045 filed Mar 11, 2026Equity incl. NCI · Q4 FY2026: $43.1B · 10-K 0001193125-26-277521 filed Jun 22, 2026Equity incl. NCI · Q1 FY2027: $67.2B · 10-Q 0001193125-26-389274 filed Sep 11, 202667.247.5Q1 FY2016Q1 FY2027Q3 FY2021
$BEquity incl. NCI · Q2 FY2025: $14.2B · 10-Q 0000950170-24-134973 filed Dec 10, 2024Equity incl. NCI · Q3 FY2025: $17.3B · 10-Q 0000950170-25-037143 filed Mar 11, 2025Equity incl. NCI · Q4 FY2025: $21.0B · 10-K 0000950170-25-087926 filed Jun 18, 2025Equity incl. NCI · Q1 FY2026: $24.7B · 10-Q 0001193125-25-200095 filed Sep 10, 2025Equity incl. NCI · Q2 FY2026: $30.5B · 10-Q 0001193125-25-315925 filed Dec 11, 2025Equity incl. NCI · Q3 FY2026: $39.1B · 10-Q 0001193125-26-101045 filed Mar 11, 2026Equity incl. NCI · Q4 FY2026: $43.1B · 10-K 0001193125-26-277521 filed Jun 22, 2026Equity incl. NCI · Q1 FY2027: $67.2B · 10-Q 0001193125-26-389274 filed Sep 11, 202667.214.2Q2 FY2025Q1 FY2027Q2 FY2026
Q1 FY2027
67.2$B
All values (45)
PeriodValue ($B)Status
Q1 FY202767.2reported
Q4 FY202643.1reported
Q3 FY202639.1reported
Q2 FY202630.5reported
Q1 FY202624.7reported
Q4 FY202521.0reported
Q3 FY202517.3reported
Q2 FY202514.2reported
Q1 FY202511.3reported
Q4 FY20249.2reported
Q3 FY20246.2reported
Q2 FY20246.2reported
Q1 FY20242.8reported
Q4 FY20231.6reported
Q3 FY2023−1.9reported
Q2 FY2023−3.8reported
Q1 FY2023−5.4reported
Q4 FY2022−5.8reported
Q3 FY2022−8.2reported
Q2 FY2022−9.7reported
Q1 FY2022−1.1reported
Q4 FY20216.0reported
Q3 FY20219.6reported
Q2 FY20218.6reported
Q1 FY202110.1reported
Q4 FY202012.7reported
Q3 FY202014.9reported
Q2 FY202016.2reported
Q1 FY202019.0reported
Q4 FY201922.4reported
Q3 FY201924.2reported
Q2 FY201931.1reported
Q1 FY201938.6reported
Q4 FY201846.9reported
Q3 FY201849.1reported
Q2 FY201856.3reported
Q1 FY201856.4reported
Q4 FY201755.1reported
Q3 FY201751.0reported
Q2 FY201748.8reported
Q1 FY201747.8reported
Q4 FY201647.8reported
Q3 FY201646.3reported
Q2 FY201646.3reported
Q1 FY201647.5reported

CSV with all sources · Technical ID: equity_total

More metrics for Oracle

Value drivers

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Sources & calculation
Value
$67.2B
Period
Q1 FY2027, ended Aug 31, 2026 · as of Aug 31, 2026 (balance as of date, not a sum)
Source
10-Q, filed Sep 11, 2026 · 0001193125-26-389274
Location
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$67.2BSep 11, 202610-Q 0001193125-26-389274reported · confidence 1. · current